Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes. Now, a clinical trial suggests the medicines can ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...

When you hear the name Ozempic, you likely think of diabetes treatment. That makes sense, as semaglutide was first approved in 2017 to help people with type 2 diabetes regulate […] ...

Mini meals with bite size portions are meant to appeal to people taking GLP-1 weight-loss drugs that reduce appetite.

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...

GLP-1 agonists, including liraglutide, are typically used to control blood sugar levels in type 2 diabetes and to promote weight loss. These drugs mimic a hormone released after eating, helping to ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. News. By Jennifer Zieba published 2 July 2025 A clinical trial for semaglutide, the active ingredient in Ozempic, found ...